Tectonic Therapeutic, Inc.

TECX Nasdaq CIK: 0001681087

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NY
Business Address 490 ARSENAL WAY, WATERTOWN, MA,
Mailing Address 490 ARSENAL WAY, WATERTOWN, MA,
Phone (339) 666-3320
Fiscal Year End 1231
EIN 810710585

Financial Overview

FY2025

$253.80M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report April 3, 2026 View on SEC
3 Initial insider ownership report April 3, 2026 View on SEC
4 Insider stock transaction report April 3, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
4/A Insider transaction amendment March 5, 2026 View on SEC

Annual Reports

10-K February 26, 2026
  • Tectonic initiated Phase 1 clinical trial for lead candidate TTX-101 (IBD) and secured IND clearance, marking its transition to clinical stage.
  • The proprietary GEODe™ platform enables development of highly specific, multi-functional biologic medicines targeting GPCRs, differentiating it from small molecule competitors.
View Analysis

Insider Trading

SELL 4 insiders 9 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.